Lidocaine is under clinical development by MEDRx and currently in Pre-Registration for Postherpetic Neuralgia. According to GlobalData, Pre-Registration drugs for Postherpetic Neuralgia have an 83% ...

lung cancer and metastatic breast cancer. It is administered through subcutaneous and intravenous route. It is generated by using dendritic cell progenitors isolated from patients. The vaccine ...

Karan Rajan argued that a person should stay clear of this certain type of mouthwash due to it increasing a person's chance of developing a type of cancer Speaking on his podcast, the British NHS ...

Dr Karan Rajan, a British surgeon who works for the NHS, has warned against certain types of mouthwash due to an increased risk of developing some forms of cancer. He stressed the importance of ...

A doctor has warned against using certain types of mouthwash. This is due to an increased risk of developing some forms of cancer. Dr Karan Rajan, a British surgeon who works for the NHS ...

A medical expert has issued a warning about the use of certain types of mouthwash due to their potential link to an increased risk of cancer. Dr Karan Rajan, a British surgeon working for the NHS ...

An effective immunotherapy would be life-changing for rectal cancer patients, with current treatments often resulting in a suite of negative outcomes in survivors, including loss of fertility and ...

Peter’s. I was struck by how similar his case was to that of another Weiner patient, Scot Warwick. Weiner had diagnosed Warwick with Stage 4 lung cancer and treated him with chemo and other therapies ...

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and will be distributed for free. The vaccine will cost the Russian government ...

“Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge.” Pre-clinical trials suggest the vaccine inhibits tumor growth and the spread of cancer, ...

In a significant medical breakthrough, Russia has reportedly developed an mRNA vaccine against cancer, which will be made available to patients free of cost by 2025. The announcement was made by ...

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025. Russia has developed an mRNA-based vaccine targeting cancer ...